While pharmaceuticals were spared the U.S. tariffs that shook world markets last week, the respite could be short-lived. The impact: 94% of biotech firms anticipate surging manufacturing costs from ...

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all ...

The Biotechnology Innovation Organization (BIO) is the world’s largest trade association representing the life sciences industry. BIO members are leading the research and development of innovative ...

Explore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company ...

BIO is in search of dynamic, professional candidates possessing the expertise and education outlined in the job titles listed below. If you are interested in working at BIO, please visit our current ...

Advocating for key government policies that support innovation in vaccines and increase access and uptake across all ages. Supporting funding and public-private partnerships with the US government ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...